SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: James Perry who wrote (686)5/13/1998 12:36:00 AM
From: Brander  Read Replies (1) | Respond to of 834
 
Agree; there is certainly still hope for Novastan, but patience will be necessary. I don't see how approval could now occur before 1999. Panic usually leads to unnecessary losses. My post was in reference to those who were trying to rub salt into the wound. This shows lack of sportsmanship and class. Today's rebound shows that Wall Street does not think TXB is sunk.

Brad



To: James Perry who wrote (686)5/14/1998 2:10:00 PM
From: gaddis  Read Replies (1) | Respond to of 834
 
Where do you see that Novastan was tested on only 20 people ? I believe the number was 304 people.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News